(Q46026571)

English

TGFbetaR2 aberrant methylation is a potential prognostic marker and therapeutic target in multiple myeloma.

scientific article published in October 2009

Statements

TGFbetaR2 aberrant methylation is a potential prognostic marker and therapeutic target in multiple myeloma (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit